{
    "Symbol": "LLY",
    "AssetType": "Common Stock",
    "Name": "Eli Lilly and Company",
    "Description": "Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.",
    "CIK": "59478",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US",
    "OfficialSite": "https://www.lilly.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "726800138000",
    "EBITDA": "16566500000",
    "PERatio": "87.18",
    "PEGRatio": "0.746",
    "BookValue": "15.82",
    "DividendPerShare": "5.03",
    "DividendYield": "0.0076",
    "EPS": "9.27",
    "RevenuePerShareTTM": "45.37",
    "ProfitMargin": "0.205",
    "OperatingMarginTTM": "0.398",
    "ReturnOnAssetsTTM": "0.14",
    "ReturnOnEquityTTM": "0.653",
    "RevenueTTM": "40863302000",
    "GrossProfitTTM": "33060801000",
    "DilutedEPSTTM": "9.27",
    "QuarterlyEarningsGrowthYOY": "0.682",
    "QuarterlyRevenueGrowthYOY": "0.204",
    "AnalystTargetPrice": "978.39",
    "AnalystRatingStrongBuy": "6",
    "AnalystRatingBuy": "16",
    "AnalystRatingHold": "6",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "87.18",
    "ForwardPE": "34.6",
    "PriceToSalesRatioTTM": "17.79",
    "PriceToBookRatio": "49.6",
    "EVToRevenue": "17.96",
    "EVToEBITDA": "58.65",
    "Beta": "0.43",
    "52WeekHigh": "970.92",
    "52WeekLow": "632.87",
    "50DayMovingAverage": "779.33",
    "200DayMovingAverage": "839.01",
    "SharesOutstanding": "899316000",
    "DividendDate": "2025-03-10",
    "ExDividendDate": "2025-02-14"
}